MyHealthchecked (MHC)

Sector:

Health Care

Index:

FTSE AIM All-Share

4.20p
   
  • Change Today:
    -0.25p
  • 52 Week High: 6.70
  • 52 Week Low: 0.80
  • Currency: UK Pounds
  • Shares Issued: 725.25m
  • Volume: 3,276,128
  • Market Cap: £30.46m
  • RiskGrade: 796
  • Beta: 0.02

Concepta launching 'myLotus' fertility product in London

By Josh White

Date: Wednesday 31 Oct 2018

LONDON (ShareCast) - (Sharecast News) - Concepta announced the launch of its 'myLotus' product for women's fertility at the Fertility Show in London on the weekend of 3-4 November on Wednesday.
The AIM-traded firm said myLotus allowed women to self-test to identify their optimal fertile days, improving their chances of naturally getting pregnant.

It said myLotus enabled women to monitor their fertile phase as part of their menstrual cycle, and was the only home test to "quantitatively" measure personalised hormone levels and the "rate-of-change" of those levels preceding ovulation, to help aid a natural conception.

Users measured, recorded and tracked their hormone levels, and followed their fertility journey in an accompanying app.

Concepta said myLotus would be available to women who were planning to start a family, or for those who had previously struggled to naturally conceive, enabling couples an alternative prior to considering more costly IVF treatment.

The Fertility Show stand would also include representation from "key opinion leaders", fertility doctors and health experts, who would be available to discuss myLotus.

"The Fertility Show marks the UK launch of our myLotus fertility product and the start of our roll-out across CE territories," said Concepta chairman Matthew Walls.

"We look forward to an exciting Fertility Show and to welcoming women and couples to our stand."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

MyHealthchecked Market Data

Currency UK Pounds
Share Price 4.20p
Change Today -0.25p
% Change -5.62 %
52 Week High 6.70
52 Week Low 0.80
Volume 3,276,128
Shares Issued 725.25m
Market Cap £30.46m
Beta 0.02
RiskGrade 796

MyHealthchecked Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
83.01% above the market average83.01% above the market average83.01% above the market average83.01% above the market average83.01% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average
Income Not Available
Growth
21.14% below the market average21.14% below the market average21.14% below the market average21.14% below the market average21.14% below the market average
22.58% below the sector average22.58% below the sector average22.58% below the sector average22.58% below the sector average22.58% below the sector average

MyHealthchecked Dividends

No dividends found

Trades for 14-May-2021

Time Volume / Share Price
16:35 17,500 @ 4.20p
16:29 9,768 @ 4.29p
16:26 8,062 @ 4.15p
16:25 11,376 @ 4.29p
15:24 186,520 @ 4.20p

MyHealthchecked Key Personnel

CEO Penelope McCormick

Top of Page